Biotech · Private company
Vigeo Therapeutics, Inc.
Track this companyFree. Adds Vigeo Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- VT1021Phase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent GlioblastomaPHASE2_PHASE3 · RECRUITING · started Jul 30, 2019ClinicalTrials.gov NCT03970447 · fetched Nov 12, 2026
- Phase 1 Study Evaluating VT1021 in Patients With Advanced Solid TumorsPHASE1 · UNKNOWN · started Nov 28, 2017ClinicalTrials.gov NCT03364400 · fetched Nov 12, 2026